Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving

The country's first convalescent plasma transfusion trial results have been peer-reviewed and published, showing 19 out of 25 patients improving with the treatment and 11 discharged from the hospital. On March 28, Houston Methodist became the first academic medical center in the nation to transfuse plasma from recovered COVID-19 patients into two critically ill patients.

from Breaking World Pharma News https://ift.tt/2z3UmbO